Yahoo Web Search

  1. Ironwood (IRWD) Q1 Earnings & Revenues Miss, Shares Fall

    Zacks via Yahoo FinanceMay 03 12:36 PM

    Ironwood Pharmaceuticals, Inc. IRWD incurred first-quarter 2019 adjusted loss of 26 cents per share, wider than the Zacks Consensus Estimate of a loss of 16 cents as well as the year-ago loss ...

  2. This week Allergan AGN and Denmark’s Novo Nordisk NVO announced their first-quarter results. Novartis NVS announced the acquisition of the rights to Takeda’s dry eye disease drug, Xiidra ...

  3. Consider This Before Buying Allergan plc (NYSE:AGN) For The 2.2% Dividend

    Simply Wall St. via Yahoo FinanceMay 16 13:20 PM

    Is Allergan plc (NYSE:AGN) a good dividend stock? Dividend paying companies with growing earnings can be highly rewarding in the long term. Yet sometimes, investors buy a popular ...

  4. Allergan Plc shareholders have voted down a non-binding proposal that sought an immediate split of the roles of chairman and chief executive, with 61.3 percent of shareholders ...

  5. For the most recent quarter, Allergan was expected to post earnings of $4.15 per share, but it reported $4.29 per share instead, representing a surprise of 3.37%. For the previous quarter ...

  6. A Backtest Approach: Do Wall Street Analysts Add Value?

    GuruFocus.com via Yahoo FinanceMay 09 16:35 PM

    .... 80.74 30 LYB LyondellBasell Industries NV 80.46 31 CVX Chevron Corp 80.39 32 DAL Delta Air Lines Inc 80.39 33 AGN Allergan PLC 79.71 34 VIAB Viacom Inc 79.18 35 REGN Regeneron Pharmaceuticals Inc 79.17 36 BHGE Baker Hughes a GE Co 78.99 37 HCA HCA...

  7. NASDAQ: PMD) Osmotica Pharmaceuticals PLC (NASDAQ: OSMT) announced positive topline results for its second Phase 3 efficacy and safety clinical trial of RVL and long-term Phase 3 safety ...

  8. Allergan: 1Q Earnings Snapshot

    Associated Press via Yahoo FinanceMay 07 11:30 AM

    The average estimate of 19 analysts surveyed by Zacks Investment Research was for earnings of $3.55 per share. The Botox maker posted revenue of $3.6 billion in the period, also beating Street ...

  9. It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

  10. PDUFA dates are deadlines for the FDA to review new drugs. The FDA is normally given 10 months to review new drugs. If a drug is selected for priority review, the FDA is allotted six months to review the drug.

  1. Ads
    related to ALLERGAN PLC